GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $187,000 | -6.0% | 4,600 | 0.0% | 0.00% | – |
| Q4 2020 | $199,000 | -21.7% | 4,600 | 0.0% | 0.00% | – |
| Q3 2020 | $254,000 | -12.4% | 4,600 | 0.0% | 0.00% | – |
| Q2 2020 | $290,000 | +23.4% | 4,600 | 0.0% | 0.00% | – |
| Q1 2020 | $235,000 | -35.8% | 4,600 | 0.0% | 0.00% | – |
| Q4 2019 | $366,000 | +64.1% | 4,600 | 0.0% | 0.00% | – |
| Q3 2019 | $223,000 | +18.0% | 4,600 | +27.8% | 0.00% | – |
| Q2 2019 | $189,000 | -1.0% | 3,600 | 0.0% | 0.00% | – |
| Q1 2019 | $191,000 | +29.1% | 3,600 | 0.0% | 0.00% | – |
| Q4 2018 | $148,000 | -70.5% | 3,600 | -67.6% | 0.00% | -100.0% |
| Q2 2018 | $502,000 | -8.1% | 11,100 | -1.8% | 0.00% | 0.0% |
| Q1 2018 | $546,000 | -78.2% | 11,300 | -82.2% | 0.00% | -75.0% |
| Q4 2017 | $2,499,000 | – | 63,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |